Skip to content

Clinical trials

Completed Myocardial Infarction trials in Bulgaria

Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.

Filters: Condition: Myocardial Infarction Status: Completed Country / region: Bulgaria Clear all

17 trials match Source: ClinicalTrials.gov registrations

Trials started per year

By phase, 2000 to 2026.

Trials started per year
CategoryTrials
20022
20061
20082
20091
20101
20111
20121
20131
20142
20151
20191
20202
20211

Status

Trials by registry status. Select a bar to filter.

Trials by status
CategoryTrials
Completed17

Top lead sponsors

A sponsor with a page on Pharma Observatory links to it.

Top lead sponsors
CategoryTrials
AstraZeneca2
Janssen Research & Development, LLC2
Novartis Pharmaceuticals2
Takeda2
Boehringer Ingelheim1
Bulgarian Cardiac Institute1
Centocor, Inc.1
GlaxoSmithKline1
Hoffmann-La Roche1
Johnson & Johnson Pharmaceutical Research & Development, L.L.C.1

Top conditions

MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.

Top conditions
CategoryTrials
Myocardial Infarction17
Acute Coronary Syndrome9
Stroke5
Angina, Unstable4
Cardiovascular Diseases3
Coronary Artery Disease3
Atherosclerosis1
COVID-191
Cardiomyopathy, Dilated1
Coronavirus Infections1

Trials

Showing 1 to 17 of 17. Each trial links to its page on Pharma Observatory.

Recently changed trials

Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.

No changes to these trials in the last 7 days.

Go deeper on Pharma Observatory

Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.